To the Editor: Coronavirus disease 2019 (COVID-19) causes severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2), which is now a global pandemic and a public threat. COVID-19 virus utilizes the angiotensin-converting enzyme 2 (ACE2) receptor, abundant in the lower respiratory tract for cellular entry.¹ Recently the editorial in your journal has mentioned a very pertinent point in the management of COVID-19 patients.¹ We would like to discuss some updates regarding the topic in this letter.

中文翻译：

---

COVID-19和ACEI / ARB：未关联？

致编辑：冠状病毒病2019（COVID-19）导致严重的急性呼吸系统综合症冠状病毒2（SARS-CoV-2），目前已成为全球大流行和公共威胁。COVID-19病毒利用在下呼吸道中丰富的血管紧张素转换酶2（ACE2）受体进入细胞。¹最近，您期刊上的社论提到了在管理COVID-19患者方面非常重要的一点。¹我们想在这封信中讨论有关该主题的一些更新。